Sujata Tyagi Dayal, Director at Emergent BioSolutions Inc. (EBS), sold 8,552 shares at $10.00 ($86K) on 2025-11-07, disclosed to the SEC on 2025-11-10.
Open-market sale of $86k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.